Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
7,714,565
-
Share change
-
+7,714,565
-
Total reported value
-
$49,665,000
-
Price per share
-
$6.43
-
Number of holders
-
11
-
Value change
-
+$49,665,212
-
Number of buys
-
11
Institutional Holders of Innate Pharma SA - SPONSORED ADS (IPHA) as of Q4 2019
As of 31 Dec 2019,
Innate Pharma SA - SPONSORED ADS (IPHA) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,714,565 shares.
The largest 10 holders included
EcoR1 Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, Rubric Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Maven Securities LTD, MILLENNIUM MANAGEMENT LLC, OXFORD ASSET MANAGEMENT LLP, OLD MISSION CAPITAL LLC, FNY Investment Advisers, LLC, and Steward Partners Investment Advisory, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.